Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey V Ravetch

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Cancer Immunity|August 17, 2012
Translating basic mechanisms of IgG effector activity into next generation cancer therapiesFalk Nimmerjahn, Jeffrey V Ravetch
Cell Cycle (Georgetown, Tex.)|August 25, 2012
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodiesFubin Li, Jeffrey V Ravetch
Immunity|January 18, 2006
Fcgamma receptors: old friends and new family membersFalk Nimmerjahn, Jeffrey V Ravetch
International Immunology|May 5, 2017
Diversification of IgG effector functionsStylianos Bournazos, Jeffrey V Ravetch
Immunity|August 17, 2017
Fcγ Receptor Function and the Design of Vaccination StrategiesStylianos Bournazos, Jeffrey V Ravetch
The Journal of Experimental Medicine|February 18, 2021
Four keys to unlock IgGFalk Nimmerjahn, Jeffrey V Ravetch
Annual Review of Immunology|March 29, 2008
Anti-inflammatory actions of intravenous immunoglobulinFalk Nimmerjahn, Jeffrey V Ravetch
Nature Reviews. Immunology|December 8, 2007
Fcgamma receptors as regulators of immune responsesFalk Nimmerjahn, Jeffrey V Ravetch
Immunological Reviews|January 31, 2017
Anti-retroviral antibody FcγR-mediated effector functionsStylianos Bournazos, Jeffrey V Ravetch
Science (New York, N.Y.)|December 3, 2005
Divergent immunoglobulin g subclass activity through selective Fc receptor bindingFalk Nimmerjahn, Jeffrey V Ravetch
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Cancer Immunity|August 17, 2012
Translating basic mechanisms of IgG effector activity into next generation cancer therapiesFalk Nimmerjahn, Jeffrey V Ravetch
Cell Cycle (Georgetown, Tex.)|August 25, 2012
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodiesFubin Li, Jeffrey V Ravetch
Immunity|January 18, 2006
Fcgamma receptors: old friends and new family membersFalk Nimmerjahn, Jeffrey V Ravetch
International Immunology|May 5, 2017
Diversification of IgG effector functionsStylianos Bournazos, Jeffrey V Ravetch
Immunity|August 17, 2017
Fcγ Receptor Function and the Design of Vaccination StrategiesStylianos Bournazos, Jeffrey V Ravetch
The Journal of Experimental Medicine|February 18, 2021
Four keys to unlock IgGFalk Nimmerjahn, Jeffrey V Ravetch
Annual Review of Immunology|March 29, 2008
Anti-inflammatory actions of intravenous immunoglobulinFalk Nimmerjahn, Jeffrey V Ravetch
Nature Reviews. Immunology|December 8, 2007
Fcgamma receptors as regulators of immune responsesFalk Nimmerjahn, Jeffrey V Ravetch
Immunological Reviews|January 31, 2017
Anti-retroviral antibody FcγR-mediated effector functionsStylianos Bournazos, Jeffrey V Ravetch
Science (New York, N.Y.)|December 3, 2005
Divergent immunoglobulin g subclass activity through selective Fc receptor bindingFalk Nimmerjahn, Jeffrey V Ravetch
Pageof 17